WO1995017862A1 - Valve - Google Patents
Valve Download PDFInfo
- Publication number
- WO1995017862A1 WO1995017862A1 PCT/SE1994/001264 SE9401264W WO9517862A1 WO 1995017862 A1 WO1995017862 A1 WO 1995017862A1 SE 9401264 W SE9401264 W SE 9401264W WO 9517862 A1 WO9517862 A1 WO 9517862A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- valve
- urethra
- patient
- accordance
- emptying
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/0004—Closure means for urethra or rectum, i.e. anti-incontinence devices or support slings against pelvic prolapse
- A61F2/0022—Closure means for urethra or rectum, i.e. anti-incontinence devices or support slings against pelvic prolapse placed deep in the body opening
Definitions
- the present invention relates to a valve intended for positioning in the urethra or similar of a patient in the upper part of the urethra, which exhibits means for emptying the patient's urine bladder or similar through the valve.
- Urinary incontinence is not life-threatening but it has a strong negative influence on Quality of Life.
- urinary incontinence causes congenital malformations of the bladder or the nerves to the bladder (e.g. myelomeningocele) , or traffic accidents with injury to the spinal cord, or pelvic floor damage at child birth, or infections of the nervous system (such as encephalitis or meningitis) .
- congenital malformations of the bladder or the nerves to the bladder e.g. myelomeningocele
- traffic accidents with injury to the spinal cord, or pelvic floor damage at child birth e.g. myelomeningocele
- infections of the nervous system such as encephalitis or meningitis
- several of the diseases of old age such as prostatic hyperplasia of Parkinson's disease, may cause urinary incontinence.
- urinary incontinence is caused either by involuntary contractions of the bladder muscle (so called unstable bladder) , or by insufficient contraction of the urethral sphincter muscle.
- Unstable bladder can be treated with medication or bladder training with good results. The situation is more problematic when the incontinence is due to a weak or damaged sphincter muscle. So far, there is no medication available that can increase the contraction of the sphincter without giving at the same time unacceptable side effects.
- the only efficient treatment today for severe cases is operation whereby an artificial sphincter is implanted around the bladder neck or urethra, controlled by the patient via an implanted pump system.
- the main purpose of the present invention is to develop a valve for placement in the urethra or any other emptying tube channel in humans or animals and to construct the valve so that it is well tolerated by the patient's urethra.
- the valve is intended to be changed regularly, for instance every 6 months, in order to prevent the development, of urinary stone and infection. Furthermore, the pressure within the device keeping the valve in adequate position within the urethra is calibrated so that the valve is well tolerated by the mucous membrane of the urethra but at the same time allowing the entire device to be expelled out of the patient's body in case the bladder pressure would rise to dangerous levels if the opening of the valve would be impaired, thus enhancing the safety of the valve.
- a valve in accordance with the present invention which is characterized essentially in that a valve body accommodated internally within a valve housing is formed by a permanent magnet, in conjunction with which a stop is situated at the inward-facing part of the valve housing, and in that drainage holes extend to the area of the central part of the valve housing and the central channel of the valve housing to permit urine to be emptied through the valve in its inserted position, and to seal the valve with the valve body in its extended position, and in that the valve is so arranged as to be positioned in the urethra, etc., and to be withdrawn from it with the help of a tool capable of being accommodated in the urethra and activated from the outside of the patient's body, in that the valve is retained in the urethra by means of holding devices with a sealing and retaining effect around the periphery of the valve, which devices are formed from self-expanding bodies, and in that the valve is adjustable from the outside of the patient's body for the
- Fig. 1 illustrates schematically the position of the valve respectively in a woman and in a man
- Fig. 2 shows a partially sectioned view of a valve activated to the open position
- Fig. 3 shows application and removal aids for the valve
- Fig. 4 shows a sectioned view of a first prototype of a valve exhibiting a manually activated valve body
- Fig. 5 shows a sectioned view of such a valve adapted for application in ' the urethra of a patient
- Fig. 6 shows an aid for applying the valve
- Fig. 7 shows a sectioned view of a further variant of a valve with retaining bodies for same;
- Fig. 8 shows a second prototype of a valve which exhibits a valve body so arranged as to be capable of activation with electrical impulses.
- a valve 1 in accordance with the present invention which is so arranged as to be positioned in an intended position in the urethra 2 or in some other duct intended for emptying in a patient, either female 3 or male 4, at the upper part 2A of the urethra, etc., in conjunction with the urine bladder 5 on the inner side of the sphincter muscle 6 of the urethra in the case of females, and the sphincter muscle 7 and prostate 8 in the case of males, and which exhibits means for emptying the patient's urine bladder 5 or some other internal body cavity intended for emptying, through the valve 1, is so arranged as to be positioned simply and without pain in the urethra 2, etc., and to be regulated externally by the patient.
- the entire valve 1 is so arranged as to be capable of being positioned in the urethra 2, etc., in its internal space 9, and of being removed from it with the help of a tool 11 intended for that purpose capable of being accommodated inside the urethra 2, etc., and activated from the outside 10 of the patient's body.
- the valve 1 in accordance with the invention is also adjustable from the outside 10 of the patient's body to permit emptying of the urine bladder 5, etc.
- Said valve 1 is retained in the urethra 2 at its inner part 2A by holding devices 12 exerting both a sealing and retaining effect around the periphery of the valve.
- Said holding devices 12 can be formed by ⁇ thickened parts 12 1 of the valve 1 at its rear end IB around its outer surface 13.
- Holding devices can also be formed from laterally extending bodies 12 11 , preferably capable of being filled with a liquid 17, for example a liquid that is harmless to the patient in the event of it being able to leak into the urethra 2, as may occur when the valve 1 is being withdrawn.
- a liquid 17 for example a liquid that is harmless to the patient in the event of it being able to leak into the urethra 2, as may occur when the valve 1 is being withdrawn.
- FIG. 5 Illustrated in Fig. 5 is an embodiment of a valve 1 in which a number of annular bodies 12 11 distributed along the longitudinal extent 14 of the valve, which bodies are formed by a common rubber balloon 15 with a common filling orifice 16 for the filling liquid 17, attached to the valve 1 around its ends with adhesive, form the aforementioned devices for holding and sealing the valve 1 against the inner surface 9A of the internal cavity 9 of the urethra.
- Illustrated in Fig. 7 is an embodiment in which such holding devices 12 111 are formed by rolls 18 of a compressible material, which rolls are applied externally around a valve 1 of the kind intended here, for example in the form of a rubber material. Said rolls 18 may be of a kind such that they swell as they come into contact with liquid, so as to achieve the effective sealing and retention of the valve in the urethra.
- the valve 1 may, as shown in drawings such as Figs. 1-7, be of a mechanical kind with a valve body 21 accommodated in such a way as to be capable of movement inside a cylindrical valve housing 20, which valve body preferably consists of a permanent magnet, in conjunction with which a stop 22 is situated in the inward-facing part IA of the valve housing, and thus the valve, i.e. that part of the valve 1 that is intended to face towards and to be inserted in the urethra 2.
- drainage holes 23 extending preferably perpendicularly through the valve 1.
- Said drainage holes 23 extend through the tubular outer casing 24 of the valve as far as an internal cavity 25 in the central part 1C of the valve housing and the transcurrent axial central channel 26 of the valve housing, for the purpose of emptying urine, etc., through the valve 1 with the valve body 21 pushed into its inserted position I, and of connecting the valve 1 to said valve body 21 when it is in its extended position, in which it is retained by the effect of the magnet, and the connected drainage holes 23 and central channel 26, thereby preventing the escape of urine through the valve 1.
- a valve seat 27 is accommodated internally in the valve housing 24 and interacts with the outward-facing end 21A, preferably in the form of a permanent magnet, of the valve body.
- the valve seat 27 is constructed preferably as a sleeve together with an appropriate and matching seal 28, for instance attached to the valve body 21, to interact with said valve body 21 between same 21 and at least one valve seat 27.
- Said valve 1 is capable of manual actuation.
- the valve body 21 For the purpose of emptying the urine bladder 5, the valve body 21 must be moved mechanically with the help of an actuating device 45, such as a catheter, a probe, a wire, or a C-shaped piece of tubing, capable of being introduced from the outside through the urethra 2 as far as the valve 1 in the direction 19 of the stop 22.
- the preferably symmetrically arranged drainage holes 23 in the valve body 1 at the base 5A of the urine bladder are opened in this way.
- the technical solution provided by the valve has already demonstrated its effectiveness in bench tests.
- the next step, which is imminent, is to evaluate the prototype in animal experiments.
- valve described here can be executed in a way that is well ' tolerated by the body, it will doubtless be possessed as an important medical advance. It
- ⁇ must be capable of being positioned by a simple cystoscopy procedure, which, in adult patients, does not even require general anaesthesia and should be performed under a local anaesthetic. Given the right surface treatment, the valve should be capable of remaining in place for at least six months, and perhaps longer, before it needs replacement. With the design of the valve described here, removal and insertion of a new valve should also be a simple procedure.
- the medical advance lies essentially in the fact that the alternative for that group of patients with a weak urethra sphincter muscle is major surgery, the outcome of which, as already mentioned, is not always satisfactory.
- CIC Clean Intermittent Catheterization
- valve body 21, which, like the valve seat 27, preferably consists of a permanent magnet, is always in the closed position if it is mechanically inactivated externally. This is made possible thanks to the force with which the magnet 21 is pulled against the valve seat 27, which preferably also consists of a permanent magnet.
- Said valve 1, which is positioned in the inner upper part 2A of the urethra, can thus be regarded as replacing a damaged or dysfunctional sphincter muscle 6,7 for an urethra 2.
- valve housing 20 and the stop 22 can be made of bronze or titanium, and the valve seat 27 and the valve body 21 can consist of permanent magnets, whilst the seal 28 can consist of a glued-on sheet of silicone rubber of the desired thickness. All components other than the seal 28 are coated with a nickel anti-corrosion treatment, which also serves as the base for subsequent plating with gold, which is inert, is not rejected by the tissues, and does not provide a point of attachment for urine crystals and bacteria.
- the application of such a valve 1 in the right situation/position in a patient is possible by causing the valve 1 to be introduced through the urethra 2 from its external opening 29 with the help of a combined application/removal tool 11, for example of the kind illustrated in the drawings in Fig. 3.
- the nipple 31 is unscrewed with the help of a rear handle 30, for example on a flexible cable 33, and is withdrawn from the urethra 2.
- a clamping sleeve 34 connects the nipple 31 to the cable 33.
- Means other than threaded devices for the attachment of insertion tools to the valve are possible, e.g. in the form of a grab claw.
- valve 1 is then retained in position in the urethra 2 with the help of the external holding devices 12 of the valve 1, at the same time as a good seal past the valve 1 is achieved so as to prevent leakage.
- the holding devices 12 11 can be filled with liquid 17 from a compressible container 35, which is connected via a filler hose 36 running internally in the flexible insertion cable 33 to the valve 1.
- a flap valve 37 which communicates with the balloon 15 attached to the valve, permits the supply of the liquid 17 to the different parts 12 11 of the ring. When removing the valve, said parts 12 11 of the ring can be punctured jointly to enable the valve 1 to be pulled out easily by means of the tool 11.
- the valve 1 which can be made in different sizes to suit the urethra and the incontinence problem of the individual patient, must be replaced at intervals of approximately six months.
- An electrically actuated valve 101 which is illustrated in the drawings in Fig. 8, permits actuation of the valve from outside the patient's body without the need for the introduction through the urethra 2 of any long devices to effect emptying.
- the valve 101 is so arranged as to be opened or closed by means of electrical impulses through so-called remote control.
- a magnetic winding 150 which exerts a pulling force 150A to close the valve 101
- a further magnetic winding 151 which exerts a pushing force 151A in the opposite direction to open the valve 101 in the area of the centre 152 of the valve.
- magnetic windings 153 and 154 which respectively exert a pushing force 153A and a pulling force 154A for the purpose respectively of closing and opening the valve 101.
- a moving valve body 121 which is preferably also in the form of a permanent magnet body of cylindrical form, is accommodated so that it is free to move in a space 125 inside the front valve housing part 120A of the valve 101 and is made of a bronze material or titanium.
- a seal 128, 128A is attached to the respective end 121A, 121B of the moving valve body 121 by means of magnetic material, enabling it to close the respective end 155, 156 of the central passageway 126 in the valve seat 120.
- the material used in the seal is preferably silicone rubber, although consideration can be given to the use of other suitable elastic material.
- the valve body 121 is self-retaining in the open/ closed position, thanks to the magnetic force, and is so arranged as to be opened/closed by means of an electrical impulse.
- the electrical impulse reverses the polarity of the seat 120 and a stop 158 inside the front part 101A of the valve, in relation to the valve body 121.
- Drainage holes 123 also lead through the part 120A of the valve housing to the internal cavity 125 beneath the valve body 121 for connection to the passageway 126.
- valve 101 When the valve 101 is positioned in the upper part of an urethra, said drainage holes 123 are situated inside the actual urine bladder, in the vicinity of its base, whereas the external attachment parts 152, etc., of the valve are attached to the urethra on its inside.
- the attachment devices 152 are appropriately of a similar kind, as described in the preceding embodiment. For approximately one ms during polarity reversal, a small pushing force acts on the part (either the seat or the stop) against which the valve body is in contact, and a stronger pulling force acts on the opposite end of the valve body.
- the valve body can also be opened mechanically independently of the closing impulses.
- the permanent magnets are preferably in equilibrium, so that a relatively small polarity reversal impulse, as described above, causes the valve body respectively to open and close the valve.
- Said valve also has attachment devices so arranged as to be filled with a suitable fluid at a pressure tolerable by the patient's mucous membranes.
- the valve which is intended to be replaced at regular intervals, for example every sixth month, by external influence, is so arranged as to be capable of being ejected automatically from the urethra, etc., if excessive pressure builds up inside the urine bladder, etc., for example if the valve opening process is impeded. There is accordingly no security risk, thanks to the safety function whereby the valve is able to leave the patient's body, which function is effective independently of the valve function.
- the electrical valve must satisfy the above criteria, apart from the possibility that insertion/removal of the electrical control means of the valve may require a minor surgical operation.
Abstract
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP7517986A JPH09507137A (en) | 1993-12-30 | 1994-12-29 | valve |
AU14294/95A AU1429495A (en) | 1993-12-30 | 1994-12-29 | Valve |
US08/666,454 US6132365A (en) | 1993-12-30 | 1994-12-29 | Valve |
EP95905834A EP0737051A1 (en) | 1993-12-30 | 1994-12-29 | Valve |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9304372-7 | 1993-12-30 | ||
SE9304372A SE504276C2 (en) | 1993-12-30 | 1993-12-30 | Valve intended to be placed in the urethra |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1995017862A1 true WO1995017862A1 (en) | 1995-07-06 |
Family
ID=20392295
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/SE1994/001264 WO1995017862A1 (en) | 1993-12-30 | 1994-12-29 | Valve |
Country Status (6)
Country | Link |
---|---|
US (1) | US6132365A (en) |
EP (1) | EP0737051A1 (en) |
JP (1) | JPH09507137A (en) |
AU (1) | AU1429495A (en) |
SE (1) | SE504276C2 (en) |
WO (1) | WO1995017862A1 (en) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0862898A2 (en) * | 1997-02-07 | 1998-09-09 | Abbeymoor Medical, Inc. | Urethral apparatus with position indicator and methods of use thereof |
US5906575A (en) * | 1996-04-25 | 1999-05-25 | Rochester Medical Corporation | Urethral urine retention device |
WO2000047141A1 (en) * | 1999-02-11 | 2000-08-17 | Universidad Complutense De Madrid Rectorado | External magnetic actuation valve for intraurethral artificial urinary sphincter |
US8864730B2 (en) | 2005-04-12 | 2014-10-21 | Rochester Medical Corporation | Silicone rubber male external catheter with absorbent and adhesive |
US9707375B2 (en) | 2011-03-14 | 2017-07-18 | Rochester Medical Corporation, a subsidiary of C. R. Bard, Inc. | Catheter grip and method |
US9872969B2 (en) | 2012-11-20 | 2018-01-23 | Rochester Medical Corporation, a subsidiary of C.R. Bard, Inc. | Catheter in bag without additional packaging |
US10092728B2 (en) | 2012-11-20 | 2018-10-09 | Rochester Medical Corporation, a subsidiary of C.R. Bard, Inc. | Sheath for securing urinary catheter |
US10857324B2 (en) | 2014-08-26 | 2020-12-08 | C. R. Bard, Inc. | Urinary catheter |
WO2022153064A1 (en) * | 2021-01-18 | 2022-07-21 | Steaton Limited | Improvements in or relating to fluid management systems |
US11547599B2 (en) | 2017-09-19 | 2023-01-10 | C. R. Bard, Inc. | Urinary catheter bridging device, systems and methods thereof |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6527702B2 (en) | 2000-02-01 | 2003-03-04 | Abbeymoor Medical, Inc. | Urinary flow control device and method |
US7141038B2 (en) * | 2000-08-07 | 2006-11-28 | Abbeymoor Medical, Inc. | Endourethral device and method |
WO2002058541A2 (en) | 2001-01-23 | 2002-08-01 | Abbeymoor Medical, Inc. | Endourethral device & method |
DE60235757D1 (en) | 2001-06-22 | 2010-05-06 | Abbeymoor Medical Inc | URETHRA PROFILING DEVICE |
ATE536198T1 (en) * | 2001-10-18 | 2011-12-15 | Abbeymoor Medical Inc | ENDOURETHRAL DEVICE |
WO2005092321A1 (en) * | 2004-03-24 | 2005-10-06 | Kissei Pharmaceutical Co., Ltd. | Pharmaceutical composition for prevention or treatment of increased urinary frequency or involuntary urination |
US7666133B2 (en) * | 2004-12-06 | 2010-02-23 | Sam Drager | Apparatus and method for correcting urinary incontinence |
CN100387311C (en) * | 2005-05-09 | 2008-05-14 | 中国人民解放军第三军医大学第一附属医院 | Leakage-preventing fixation-free bead string type drainage tube |
US8992410B2 (en) | 2010-11-03 | 2015-03-31 | Vysera Biomedical Limited | Urological device |
RU2727038C2 (en) * | 2010-11-03 | 2020-07-17 | Колопласт А/С | Urological device |
US9763762B2 (en) | 2013-09-25 | 2017-09-19 | Medtronic, Inc. | Implantable urinary tract valve |
US9775698B2 (en) | 2015-01-23 | 2017-10-03 | Spinal Singularity, Inc. | Urinary prosthesis systems |
US10675435B2 (en) * | 2015-04-01 | 2020-06-09 | Spinal Singularity, Inc. | Extended-use valved urinary catheter |
CA2974108C (en) * | 2015-01-23 | 2024-03-19 | Spinal Singularity Inc. | Bladder management systems |
US11510765B2 (en) | 2015-01-23 | 2022-11-29 | Spinal Singularity, Inc. | Extended-use catheters |
US11065093B2 (en) | 2015-01-23 | 2021-07-20 | Spinal Singularity, Inc. | Catheter mating devices |
US10751506B2 (en) | 2015-04-01 | 2020-08-25 | Spinal Singularity, Inc. | Catheters and catheter mating devices and systems |
US11896823B2 (en) | 2017-04-04 | 2024-02-13 | Btl Healthcare Technologies A.S. | Method and device for pelvic floor tissue treatment |
US11628271B2 (en) | 2019-06-10 | 2023-04-18 | Spinal Singularity, Inc. | Urinary catheter |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0182409A1 (en) * | 1984-10-17 | 1986-05-28 | Applied Medical Technics B.V. | Implantable shut-off device |
US5004454A (en) * | 1989-02-15 | 1991-04-02 | Technion Research And Development Foundation Ltd. | Auxiliary intra-urethral magnetic valve for persons suffering from urinary incontinence |
US5030199A (en) * | 1989-12-11 | 1991-07-09 | Medical Engineering Corporation | Female incontinence control device with magnetically operable valve and method |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3812841A (en) * | 1972-08-21 | 1974-05-28 | L Isaacson | Urethra magnetic valve structure |
DE3821631A1 (en) * | 1987-07-28 | 1989-02-09 | Bader Paul | CLOSURE FOR A MALE UTILITY |
US5509427A (en) * | 1990-12-31 | 1996-04-23 | Uromed Corporation | Urethral plug assembly having adhesive for enhanced sealing capabilities and method of using said plug assembly |
GB9202247D0 (en) * | 1992-02-03 | 1992-03-18 | British Tech Group | Prosthetic sphincter device |
US5352182A (en) * | 1992-05-27 | 1994-10-04 | Kalb Irvin M | Product and method to treat female incontinence |
-
1993
- 1993-12-30 SE SE9304372A patent/SE504276C2/en not_active IP Right Cessation
-
1994
- 1994-12-29 EP EP95905834A patent/EP0737051A1/en not_active Withdrawn
- 1994-12-29 AU AU14294/95A patent/AU1429495A/en not_active Abandoned
- 1994-12-29 WO PCT/SE1994/001264 patent/WO1995017862A1/en not_active Application Discontinuation
- 1994-12-29 US US08/666,454 patent/US6132365A/en not_active Expired - Fee Related
- 1994-12-29 JP JP7517986A patent/JPH09507137A/en not_active Ceased
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0182409A1 (en) * | 1984-10-17 | 1986-05-28 | Applied Medical Technics B.V. | Implantable shut-off device |
US5004454A (en) * | 1989-02-15 | 1991-04-02 | Technion Research And Development Foundation Ltd. | Auxiliary intra-urethral magnetic valve for persons suffering from urinary incontinence |
US5030199A (en) * | 1989-12-11 | 1991-07-09 | Medical Engineering Corporation | Female incontinence control device with magnetically operable valve and method |
Cited By (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5906575A (en) * | 1996-04-25 | 1999-05-25 | Rochester Medical Corporation | Urethral urine retention device |
US6315711B1 (en) | 1996-04-25 | 2001-11-13 | Rochester Medical Corporation | Urethral urine retention device |
US6479000B2 (en) | 1996-04-25 | 2002-11-12 | Rochester Medical Corporation | Urethral urine retention device |
EP0862898A2 (en) * | 1997-02-07 | 1998-09-09 | Abbeymoor Medical, Inc. | Urethral apparatus with position indicator and methods of use thereof |
EP0862898A3 (en) * | 1997-02-07 | 1999-07-07 | Abbeymoor Medical, Inc. | Urethral apparatus with position indicator and methods of use thereof |
WO2000047141A1 (en) * | 1999-02-11 | 2000-08-17 | Universidad Complutense De Madrid Rectorado | External magnetic actuation valve for intraurethral artificial urinary sphincter |
ES2150881A1 (en) * | 1999-02-11 | 2000-12-01 | Univ Madrid Complutense | External magnetic actuation valve for intraurethral artificial urinary sphincter |
AU760625B2 (en) * | 1999-02-11 | 2003-05-22 | Laboratorios Indas, S.A. | External magnetic actuation valve for intraurethral artificial urinary sphincter |
US6623421B1 (en) | 1999-02-11 | 2003-09-23 | Universidad Complutense De Madrid | External magnetic actuation valve for intraurethral artificial urinary sphincter |
US9248058B2 (en) | 2005-04-12 | 2016-02-02 | Rochester Medical Corporation, a subsidiary of C.R. Bard, Inc. | Male external catheter with absorbent and adhesive |
US8864730B2 (en) | 2005-04-12 | 2014-10-21 | Rochester Medical Corporation | Silicone rubber male external catheter with absorbent and adhesive |
US11607524B2 (en) | 2011-03-14 | 2023-03-21 | Rochester Medical Corporation | Catheter grip and method |
US9707375B2 (en) | 2011-03-14 | 2017-07-18 | Rochester Medical Corporation, a subsidiary of C. R. Bard, Inc. | Catheter grip and method |
US10569051B2 (en) | 2011-03-14 | 2020-02-25 | Rochester Medical Corporation, a subsidiary of C. R. Bard, Inc. | Catheter grip and method |
US9872969B2 (en) | 2012-11-20 | 2018-01-23 | Rochester Medical Corporation, a subsidiary of C.R. Bard, Inc. | Catheter in bag without additional packaging |
US10092728B2 (en) | 2012-11-20 | 2018-10-09 | Rochester Medical Corporation, a subsidiary of C.R. Bard, Inc. | Sheath for securing urinary catheter |
US10780244B2 (en) | 2012-11-20 | 2020-09-22 | Rochester Medical Corporation, a subsidiary of C. R. Bard, Inc. | Catheter in a bag without additional packaging |
US11730919B2 (en) | 2012-11-20 | 2023-08-22 | Rochester Medical Corporation | Catheter in bag without additional packaging |
US10857324B2 (en) | 2014-08-26 | 2020-12-08 | C. R. Bard, Inc. | Urinary catheter |
US10874825B2 (en) | 2014-08-26 | 2020-12-29 | C. R. Bard, Inc. | Urinary catheter |
US11850370B2 (en) | 2014-08-26 | 2023-12-26 | C. R. Bard, Inc. | Urinary catheter |
US11547599B2 (en) | 2017-09-19 | 2023-01-10 | C. R. Bard, Inc. | Urinary catheter bridging device, systems and methods thereof |
WO2022153064A1 (en) * | 2021-01-18 | 2022-07-21 | Steaton Limited | Improvements in or relating to fluid management systems |
Also Published As
Publication number | Publication date |
---|---|
SE9304372D0 (en) | 1993-12-30 |
SE9304372L (en) | 1995-07-01 |
US6132365A (en) | 2000-10-17 |
EP0737051A1 (en) | 1996-10-16 |
AU1429495A (en) | 1995-07-17 |
SE504276C2 (en) | 1996-12-23 |
JPH09507137A (en) | 1997-07-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6132365A (en) | Valve | |
US3503400A (en) | Urethral valve | |
US5749826A (en) | Urinary incontinence control device | |
EP0798994B1 (en) | Urinary incontinence device | |
US20110098684A1 (en) | Catheter device for the control of liquid discharge from the urinary bladder by a user person | |
US3903894A (en) | Implantable clamp | |
EP2422755B1 (en) | Urination control device | |
US6231501B1 (en) | Urinary occlusion device | |
EP0264258A2 (en) | Urinary incontinence device | |
US20090216071A1 (en) | Pessary Device | |
CZ190594A3 (en) | Apparatus for correction light urea incontinence of a woman | |
CA2401081C (en) | Method and device for intra-urethral incontinence | |
US20090018385A1 (en) | Urethra pressure control valve to control incontinence | |
WO2014205271A1 (en) | Artificial sphincter | |
US6558312B2 (en) | Intraurethral device for incontinence | |
US7125377B2 (en) | Valve assembly | |
CN112754728A (en) | Artificial urethra and artificial urethra implantation kit | |
US20100331608A1 (en) | Surgically implantable urethra pressure control valve | |
US10299904B2 (en) | Device for male urinary incontinence | |
CA2635157A1 (en) | Catheter device for the control of liquid discharge from the urinary bladder by a user person | |
US20210177566A1 (en) | Artificial urethral sphincter | |
JPH063347U (en) | Intermittent urethral indwelling catheter set | |
Choe et al. | Clinical usefulness of urinary control urethral insert devices | |
CA2668299A1 (en) | Catheter device for the control of liquid discharge from the urinary bladder by a user person | |
WO2001024843A2 (en) | Female urinary incontinence catheter |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AM AT AU BB BG BR BY CA CH CN CZ DE DK ES FI GB GE HU JP KE KG KP KR KZ LK LT LU LV MD MG MN MW NL NO NZ PL PT RO RU SD SE SI SK TJ TT UA US UZ VN |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): KE MW SD SZ AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1995905834 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 08666454 Country of ref document: US |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: 1995905834 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: CA |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1995905834 Country of ref document: EP |